Research suggests that Rhodiola rosea may exert stress-relieving effects in part through anti-inflammatory mechanisms at the cellular level. The available evidence on this specific mechanistic question comes from a single laboratory study using cultured brain immune cells, which found that a Rhodiola extract suppressed key inflammatory signaling pathways activated by a stress hormone, including reductions in NF-κB activity and related enzymes. While these findings offer a plausible molecular explanation for the adaptogenic properties traditionally attributed to the plant, the study was conducted in vitro and cannot be directly extrapolated to human stress relief. Broader clinical evidence from human trials would be needed to draw more definitive conclusions about its effectiveness for this purpose.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cel... | Other | 2020 | Supports | 72 |